Skip to main content
Retour
Watch Compare

Monopar Therapeutics

Qualité des données : 100%
MNPR
Nasdaq Manufacturing Chemicals
57,28 €
▼ 0,75 € (-1,29%)
Cap. Boursière: 385,07 M
Prix
57,28 €
Cap. Boursière
385,07 M
Fourchette du Jour
55,90 € — 58,39 €
Fourchette 52 Semaines
28,40 € — 105,00 €
Volume
315 592
Ouverture 57,33 €
Moyenne 50J / 200J
58,30 €
1,76% below
Moyenne 50J / 200J
61,03 €
6,15% below

Quick Summary

Points Clés

Negative free cash flow of -12,20 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-14,16%
Au-dessus de la moyenne du secteur (-53,41%)
ROIC-13,61%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio56,10
Interest CoverageN/A

Valorisation

PE (TTM)
-28,07
En dessous de la moyenne du secteur (-1,48)
P/B Ratio2,72
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -28,1 -1,5
P/B 2,7 1,6
ROE % -14,2 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -13,72 M
ROE -14,16% ROA -13,85%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12,20 M
ROIC -13,61% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 56,10
Interest Coverage N/A Asset Turnover 0,00
Working Capital 141,52 M Tangible Book Value 141,56 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -28,07 Forward P/E N/A
P/B Ratio 2,72 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3,17%
Market Cap 385,07 M Enterprise Value 257,39 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,00
FCF / Share -1,82 OCF / Share -1,82
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88,95%
SBC-Adj. FCF -16,13 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 — —
Net Income -13,72 M -15,59 M -8,40 M -10,52 M -9,10 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -16,70 M -16,16 M -8,83 M -10,54 M -9,13 M
EBITDA — — — — —
R&D Expenses 9,90 M 13,01 M 5,60 M 7,59 M 6,49 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — 429 039,0 21 239,0 24 024,0
Income Tax 800,0 800,0 800,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 140,72 M 60,29 M 7,35 M 13,23 M 20,52 M
Total Liabilities 2,89 M 5,25 M 1,76 M 3,14 M 1,58 M
Shareholders' Equity 137,83 M 55,04 M 5,59 M 10,09 M 18,94 M
Total Debt — — — — —
Cash & Equivalents 61,83 M 45,82 M 7,27 M 8,19 M 20,30 M
Current Assets 140,46 M 60,29 M 7,33 M 13,17 M 20,52 M
Current Liabilities 2,74 M — 1,76 M 3,13 M —